News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,630 Results
Type
Article (69080)
Company Profile (221)
Press Release (625329)
Multimedia
Podcasts (69)
Webinars (12)
Section
Business (188114)
Career Advice (2827)
Deals (33617)
Drug Delivery (106)
Drug Development (82987)
Employer Resources (159)
FDA (16873)
Job Trends (15019)
News (331251)
Policy (33620)
Tag
Academia (2920)
Academic (1)
Accelerated approval (7)
Adcomms (26)
Allergies (91)
Alliances (51460)
ALS (101)
Alzheimer's disease (1461)
Antibody-drug conjugate (ADC) (162)
Approvals (16848)
Artificial intelligence (286)
Autoimmune disease (25)
Automation (15)
Bankruptcy (343)
Best Places to Work (11663)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (152)
Bladder cancer (88)
Brain cancer (32)
Breast cancer (324)
Cancer (2531)
Cardiovascular disease (186)
Career advice (2371)
Career pathing (34)
CAR-T (179)
Cell therapy (488)
Cervical cancer (22)
Clinical research (67155)
Collaboration (923)
Company closure (2)
Compensation (371)
Complete response letters (26)
COVID-19 (2737)
CRISPR (48)
C-suite (259)
Cystic fibrosis (109)
Data (2401)
Decentralized trials (2)
Denatured (21)
Depression (50)
Diabetes (276)
Diagnostics (6572)
Digital health (19)
Diversity (7)
Diversity, equity & inclusion (38)
Drug discovery (129)
Drug pricing (119)
Drug shortages (26)
Duchenne muscular dystrophy (104)
Earnings (70406)
Editorial (44)
Employer branding (20)
Employer resources (140)
Events (95477)
Executive appointments (769)
FDA (18320)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (815)
Gene editing (113)
Generative AI (29)
Gene therapy (346)
GLP-1 (756)
Government (4692)
Grass and pollen (6)
Guidances (173)
Healthcare (18977)
Huntington's disease (20)
IgA nephropathy (29)
Immunology and inflammation (133)
Indications (31)
Infectious disease (2893)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (104)
Interviews (534)
IPO (15431)
IRA (40)
Job creations (3776)
Job search strategy (1975)
Kidney cancer (11)
Labor market (37)
Layoffs (480)
Leadership (23)
Legal (7519)
Liver cancer (82)
Lung cancer (356)
Lymphoma (168)
Machine learning (9)
Management (55)
Manufacturing (336)
MASH (81)
Medical device (12352)
Medtech (12355)
Mergers & acquisitions (18759)
Metabolic disorders (724)
Multiple sclerosis (90)
NASH (20)
Neurodegenerative disease (111)
Neuropsychiatric disorders (27)
Neuroscience (2059)
NextGen: Class of 2025 (6651)
Non-profit (4929)
Now hiring (32)
Obesity (372)
Opinion (251)
Ovarian cancer (85)
Pain (98)
Pancreatic cancer (90)
Parkinson's disease (162)
Partnered (24)
Patents (256)
Patient recruitment (124)
Peanut (48)
People (55762)
Pharmaceutical (54)
Pharmacy benefit managers (22)
Phase I (21020)
Phase II (29361)
Phase III (21950)
Pipeline (1487)
Policy (156)
Postmarket research (2862)
Preclinical (9380)
Press Release (68)
Prostate cancer (115)
Psychedelics (35)
Radiopharmaceuticals (268)
Rare diseases (421)
Real estate (6015)
Recruiting (66)
Regulatory (23696)
Reports (36)
Research institute (2625)
Resumes & cover letters (453)
Rett syndrome (7)
RNA editing (5)
RSV (45)
Schizophrenia (79)
Series A (136)
Series B (94)
Service/supplier (10)
Sickle cell disease (56)
Special edition (20)
Spinal muscular atrophy (158)
Sponsored (34)
Startups (3515)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (49)
The Weekly (47)
Vaccines (767)
Venture capitalists (39)
Weight loss (241)
Women's health (36)
Worklife (18)
Date
Today (124)
Last 7 days (883)
Last 30 days (3399)
Last 365 days (31746)
2025 (12345)
2024 (34402)
2023 (38999)
2022 (49971)
2021 (54271)
2020 (53153)
2019 (46737)
2018 (35617)
2017 (32716)
2016 (32177)
2015 (37475)
2014 (30413)
2013 (27120)
2012 (28094)
2011 (28787)
2010 (27639)
Location
Africa (967)
Alabama (58)
Alaska (6)
Arizona (188)
Arkansas (12)
Asia (42638)
Australia (7517)
California (6179)
Canada (2058)
China (564)
Colorado (269)
Connecticut (289)
Delaware (148)
Europe (96371)
Florida (919)
Georgia (199)
Idaho (58)
Illinois (562)
India (27)
Indiana (302)
Iowa (10)
Japan (177)
Kansas (103)
Kentucky (25)
Louisiana (14)
Maine (71)
Maryland (912)
Massachusetts (4534)
Michigan (225)
Minnesota (362)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (24)
Nevada (68)
New Hampshire (61)
New Jersey (1786)
New Mexico (30)
New York (1837)
North Carolina (986)
North Dakota (9)
Northern California (2688)
Ohio (215)
Oklahoma (14)
Oregon (38)
Pennsylvania (1314)
Puerto Rico (14)
Rhode Island (29)
South America (1262)
South Carolina (28)
South Dakota (1)
Southern California (2358)
Tennessee (101)
Texas (958)
United States (23345)
Utah (177)
Virginia (160)
Washington D.C. (65)
Washington State (566)
West Virginia (2)
Wisconsin (65)
694,630 Results for "frederick national laboratory for cancer research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Precision for Medicine Opens Expanded State-of-the-Art Biomarker Research and Companion Diagnostic Laboratory in Frederick, Maryland
Precision for Medicine, a global leader in biomarker-driven clinical research and development supporting life sciences companies, announced the completion of a major expansion to its laboratory campus in Frederick, Maryland.
May 14, 2024
·
3 min read
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Business
Cancer Research Institute Awards Ananda Goldrath, Ph.D., with the 2023 Frederick W. Alt Award
The Cancer Research Institute has awarded Ananda Goldrath, Ph.D., Executive Vice President and Director of the Allen Institute for Immunology, the 2023 Frederick W. Alt Award.
October 30, 2023
·
3 min read
Press Releases
Brain Cancer Canada Grants McGill University $100,000 to Advance Pediatric Brain Cancer Research
May 12, 2025
·
3 min read
Press Releases
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
April 30, 2025
·
12 min read
Press Releases
Genprex Announces Research Collaborators’ Abstract Published in Cancer Research Supplement Proceedings
April 22, 2025
·
8 min read
Press Releases
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
April 23, 2025
·
5 min read
Press Releases
City of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual Meeting
April 25, 2025
·
15 min read
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
As Q1 2025 earnings season continues, tariffs remain top of mind for pharma CEOs and investors. Meanwhile, the American Association for Cancer Research’s annual event kicks off this year’s oncology conference season. Plus, will the FDA become politicized under HHS Secretary RFK Jr.?
April 30, 2025
·
1 min read
·
Heather McKenzie
1 of 69,463
Next
